Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAS-BC: UFT vs CMF as Postoperative Adjuvant Therapy in High-Risk Breast Cancer
jRCT1080220055Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tegafur + uracil in breast cancer (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
tegafur + uracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT1080220055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220055.